Hematologic Malignancies
Powering better decisions for you and your patients
Our comprehensive hematology test menu and expertise equip you with detailed reports and deep scientific insights to provide you with the most accurate diagnoses and risk stratifications for your patients.
Featured tests and services
IntelliGEN® Myeloid
A next generation sequencing assay evaluating 50 genes associated with myeloid malignancies.
Comprehensive Hematopathology Analysis
A Labcorp hematopathologist selects medically necessary testing following a rules-based approach.
Explore Our Test Menu
Our comprehensive menu features more than 450 single analyte and multi-marker tests to provide critical insights you need at every step of the patient journey.
Labcorp is a Children's Oncology Group (COG) Approved Laboratory
Which Labcorp locations perform COG testing?
North Carolina Connecticut/New York |
Which tests are typically ordered on a COG case?
| ALL MRD by Flow Cytometry |
| ||
| Cytogenetics (karyotyping) | |||
| FISH | AML FISH Profile
| B-ALL Standard Risk Panel
| B-ALL High Risk Panel
|
ALL MRD by Flow Cytometry
|
| Cytogenetics (karyotyping) |
FISH AML FISH Profile
B-ALL Standard Risk Panel
B-ALL High Risk Panel
|
All labs performing COG tests are COG-approved and follow COG protocols and standards for COG clinical trials.
Expertise You Can Trust
45+
Over forty-five board-certified hemato-pathologists and PhD geneticists focus on our hematopathology services including results analysis, reporting, and consultative support.
375,000+
With over 375,000 hematology/oncology tests performed annually, you and your patients will benefit from our streamlined processes and expertise in the analysis and reporting of a vast variety of cases.
87%
Pivotal in the development of 87% of all drugs approved by the FDA in 2020, including 100% of the oncology drugs approved by the FDA.
Sponsored Testing Program
Blueprint’s Biomarker Testing Program
No-charge KIT D816V testing for Systemic Mastocytosis provided by Labcorp Oncology for eligible patients through the sponsored testing program from Blueprint Medicines. Early biomarker testing using a non-invasive, highly sensitive, and quantitative KIT D816V test may reduce a patient’s time to diagnosis.
Meet our team
-
You can trust our team of hematopathology experts
With decades of experience in hematopathology, our medical staff and laboratory professionals bring deep knowledge and wide-ranging technical expertise. Our experts are also available for consultation and follow-up queries on your patient’s report.
